Renaissance Capital has updated the 2018 US IPO Annual Review with returns through December 31. Download a free Preview of the report, and sign up for IPO market updates delivered to your...read more
Six IPOs raised $2.9 billion this week. Four traded up over 40%, and none finished the week below issue. Spun out of Eli Lilly, Elanco Animal Health (ELAN) priced above its range to raise $1.5 billion. The company popped 50% on its...read more
Elanco Animal Health (ELAN) raised $1.5 billion and popped 50% on Thursday. The Eli Lilly spin-off had a better first-day return than any billion-dollar IPO since Twitter in 2013 (+73%). Higher than Snap in 2017 (+44%), Alibaba in 2014 (+36%), and close peer...read more
Elanco Animal Health, a spin-off of Eli Lilly's global animal health medicines and vaccines business, raised $1.5 billion by offering 62.9 million shares at $24, above the range of $20 to $23. Elanco Animal Health plans to list on the NYSE under the symbol...read more
Renaissance Capital's Updated 2018 US IPO Annual Review
Renaissance Capital has updated the 2018 US IPO Annual Review with returns through December 31. Download a free Preview of the report, and sign up for IPO market updates delivered to your...read more
US IPO Weekly Recap: 4 IPOs pop 40% including Eventbrite, Farfetch and Elanco
Six IPOs raised $2.9 billion this week. Four traded up over 40%, and none finished the week below issue. Spun out of Eli Lilly, Elanco Animal Health (ELAN) priced above its range to raise $1.5 billion. The company popped 50% on its...read more
Elanco up 50% in best billion-dollar IPO pop in 5 years
Elanco Animal Health (ELAN) raised $1.5 billion and popped 50% on Thursday. The Eli Lilly spin-off had a better first-day return than any billion-dollar IPO since Twitter in 2013 (+73%). Higher than Snap in 2017 (+44%), Alibaba in 2014 (+36%), and close peer...read more
Elanco Animal Health prices IPO at $24, above the range
Elanco Animal Health, a spin-off of Eli Lilly's global animal health medicines and vaccines business, raised $1.5 billion by offering 62.9 million shares at $24, above the range of $20 to $23. Elanco Animal Health plans to list on the NYSE under the symbol...read more